Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hemodial Int ; 26(3): E27-E30, 2022 07.
Artigo em Inglês | MEDLINE | ID: mdl-35441472

RESUMO

Ceftriaxone is a third-generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceftriaxone. We experienced two cases of ceftriaxone-induced encephalopathy that were successfully treated by rapid removal of ceftriaxone by hemoperfusion.


Assuntos
Encefalopatias , Hemoperfusão , Síndromes Neurotóxicas , Antibacterianos/efeitos adversos , Encefalopatias/induzido quimicamente , Ceftriaxona/efeitos adversos , Humanos , Síndromes Neurotóxicas/etiologia , Diálise Renal/efeitos adversos
2.
Nihon Kokyuki Gakkai Zasshi ; 49(5): 349-54, 2011 May.
Artigo em Japonês | MEDLINE | ID: mdl-21688642

RESUMO

A 23-year-old man was admitted for examination of an abnormal shadow in the right lower lung field. A chest CT scan revealed a nodule in the right lower lobe and a calcified nodule in the right upper lobe. A diagnosis of lung adenocarcinoma in the right lower lobe was made by transbronchial cytology. After resection of the right lower lobe and partial resection of the nodule in the right upper lobe were performed, we diagnosed lung adenocarcinoma in the right lower lobe (pathological stage IIIA) and hamartoma in the right upper lobe. Although several authors have reported cases of synchronous pulmonary hamartoma and lung cancer, it is uncommon in young patients. Since patients with hamartoma could also have lung carcinoma, careful observation is needed.


Assuntos
Adenocarcinoma/complicações , Hamartoma/complicações , Pneumopatias/complicações , Neoplasias Pulmonares/complicações , Adulto , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...